DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

FDA okays Philips' MR-only radiotherapy simulator, MRCAT pelvis Create treatment plans for bladder, rectal, anal and cervical cancer

Varian to acquire Cancer Treatment Services International for $283 million Enables production of multidisciplinary solutions

Varian acquires CyberHeart, enters cardiac radioablation market Emerging technology could benefit treatment of irregular heartbeats

New 12-year study highlights value of PRRT, based on long-term outcomes Understanding peptide receptor radionuclide therapy

Korean cancer center aims to deploy heavy ion therapy in 2022 Plans also call for the onboarding of more CR and MR systems

Radiation oncologists appeal to Congress to safeguard radiotherapy treatment Protecting cancer patients' access to value-based care

Using ERISA to end proton therapy denials Insights from Timothy J. Rozelle and Lisa S. Kantor, from Kantor & Kantor, LLP on getting insurers to provide coverage

Philips unveils IntelliSpace Radiation Oncology system at ESTRO Manages complexity and efficiency of radiology departments

Elekta sues ZAP Surgical Systems, claiming patent infringement Over design and sale of ZAP's radiosurgery platform

Studies unveil measures for reducing resistance to radiotherapy in tumors Stimulates immune system to attack cancer cells

RefleXion BgRT system

RefleXion Medical secures $60 million for approval and launch of BgRT system

por John R. Fischer , Staff Reporter
RefleXion Medical has collected a $60 million loan for the approval and launch of its biology-guided radiotherapy (BgRT) system.

Provided by Oxford Finance, the senior secured term loan will fund the completion of the FDA clearance process for the system, which is the first to combine anatomical CT and functional PET capabilities for guided personalized radiotherapy, according to Todd Powell, president and CEO of RefleXion Medical.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



"Conventional radiotherapy uses images taken from outside the body to guide radiotherapy delivery. In contrast, the RefleXion machine is designed to use the emissions from PET to guide radiotherapy delivery from within the body,” he told HCB News. “As the PET tracer accumulates in the cancer itself, emissions are detected by our machine, which then delivers a beamlet of radiation directly to the tumor in real time.”

The system is designed to treat all forms of cancer at any stage, including metastatic disease, and is designed to localize multiple tumors in parallel. Users simply apply the PET tracer, which accumulates into each cancer, setting off continuous signals that are picked up by the system to indicate the location of each. The scanner then applies radiotherapy to attack, reduce and ultimately, eliminate them all in the same session.

It also can detect and deliver treatment to tumors in motion, and could enable providers to even apply radiotherapy for the first time to patients with stage four cancer.

“We are combining PET, the gold standard in visualizing and assessing cancer, with radiotherapy, a very effective way to treat cancer,” said Powell. “Our machine is designed to one day treat multiple tumors in parallel during the same session, enabling definitive radiotherapy for stage 4 cancer patients for the first time."

A work in progress over the past 10 years, the solution made its debut this past fall at the American Society of Radiation Oncology Annual Meeting in San Antonio, Texas.

RefleXion is currently in talks with the FDA and hopes to begin installations in the first half of next year.

Armentum Partners served as financial advisor to RefleXion Medical in regard to its deal with Oxford Finance.

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente a Sua Perceção da Marca
Leilões + Vendas Privadas
Comece
O mais melhor preço
Comprar Equipamento/Peças
Encontre
O preço o mais baixo
Notícia diária
Leia
A notícia a mais atrasada
Diretório
Browse tudo
DOTmed Usuários
Ética no DOTmed
Veja o nosso
Programa das éticas
O ouro parte o programa do vendedor
Receba PH
Pedidos
Programa do negociante do serviço do ouro
Receba RFP/PS
Pedidos
Fornecedores de Healthcare
Veja tudo
Ferramentas de HCP
Trabalhos/Treinamento
Achado/suficiência
Um trabalho
Parts Hunter +EasyPay
Comece as peças
Citações
Certificado recentemente
Vista recentemente
Usuários certificados
Recentemente Rated
Vista recentemente
Usuários certificados
Central Rental
Equipamento do aluguel
Para menos
Vender Equipamentos/Peças
Comece
A maioria de dinheiro
Preste serviços de manutenção ao Forum dos técnicos
Ajuda do achado
E conselho
Simples RFP
Comece o equipamento
Citações
Mostra de comércio virtual
Serviço do achado
Para o equipamento
O acesso e o uso deste local são sujeitos aos termos e às condições do nosso OBSERVAÇÃO LEGAL & OBSERVAÇÃO DA PRIVACIDADE
Propriedade de e proprietário DOTmeda .com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
TODOS OS DIREITOS RESERVADOS